Mast cell tumor radiation
therapy for dogs
in Florida.
Mast cell tumors are the most common skin cancer in dogs. When surgery leaves incomplete margins — or the location makes wide excision impossible — radiation therapy significantly reduces recurrence and extends disease-free survival.
Incomplete margins after surgery
are not the end of treatment.
Mast cell tumors are highly variable — some behave indolently for years; others grow aggressively and metastasize early. The most critical local control decision comes after surgery: when histopathology reveals incomplete or narrow margins, adjuvant radiation can prevent local recurrence in the majority of cases.
The location of a mast cell tumor frequently determines how wide a surgical margin is achievable. Tumors on the muzzle, digits, prepuce, perianal region, and distal limbs often cannot be excised with the recommended 2–3 cm margins without causing significant functional or cosmetic compromise. In these locations, radiation therapy becomes the essential complement to surgery — treating the microscopic disease remaining at the margins with precision.
Grade matters — and so does timing
Patnaik Grade II (intermediate) and Kiupel Low-Grade MCTs have the strongest evidence base for adjuvant radiation. 1-year local control rates of 85–90% have been reported when radiation therapy follows incomplete excision. High-grade tumors benefit from local control as well, but require attention to systemic therapy because of their significant metastatic risk. Radiation usually begins once the surgical wound has healed.
Inoperable mast cell tumors
When surgery is not possible — due to tumor location, size, or the owner's preference — radiation can be used as the primary local treatment. Definitive radiation therapy or palliative protocols can achieve meaningful tumor reduction, symptom relief, and local control without surgery.
Scientific references.
The clinical information on this page is grounded in peer-reviewed veterinary radiation oncology literature.
- Lejeune A, et al. (2015). Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumours. Vet Comp Oncol.
- Al-Sarraf R, et al. (1996). A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med.
- Mason SL, et al. (2020). Outcomes of adjunctive radiation therapy for the treatment of mast cell tumors in dogs and assessment of toxicity: a multicentre observational study. Vet Comp Oncol.
- Chaffin K, Thrall DE (2002). Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Vet Radiol Ultrasound.
- Hahn KA, King GK, Carreras JK (2004). Efficacy of radiation therapy for incompletely resected grade III mast cell tumors in dogs: 31 cases. J Am Vet Med Assoc. 224(1):79.
Prompt response.
Dr. DiBernardi is on site and personally reviews every case. Tell us about your dog and we'll respond promptly with a clear recommendation.
Request a Consultationa mast cell tumor.
Submit a referral and receive prompt acknowledgment. We review the surgical pathology and coordinate radiation with your oncology team.
Referral Information →